Alaska high court revives opioid lawsuit against pharmacy operators

Alaska's top court ruled on Friday that the state can pursue a lawsuit alleging pharmacies operated by Albertsons and Kroger ...

Compassion Behavioral Health Publishes New Resource on Morphine Addiction, Detox Planning, and Integrated Recovery Treatment

HOLLYWOOD, FL - November 06, 2026 - PRESSADVANTAGE - Compassion Behavioral Health has published a new educational ...
BioSpace

Curonix Freedom® Peripheral Nerve Stimulator (PNS) System Named Top New Pain Management Technology in Orthopedics This Week’s Inaugural 2026 Awards

Curonix, a leading medical technology company dedicated to relieving chronic pain, today announced that the Freedom® ...
Tri-Cities Area Journal of Business

Albertsons must pay $900M for role in WA opioid crisis, judge rules

Grocery giant Albertsons must pay Washington state $900 million for its pharmacies’ role in fueling the opioid epidemic, a ...
Pain News Network

Sicker Americans More Likely to Misuse Medication

By Pat Anson What makes someone “misuse” a medication? Does it mean they’re addicted? Are they trying to get high? Do they ...
PsyPost

Loving-kindness meditation fails to beat muscle relaxation for pain or social well-being in online trial

Loving-kindness meditation is meant to foster warmth toward others, but in a four-week online trial, it did not boost social ...

Grace Point Treatment Center Releases New Opioid Withdrawal Timeline Resource Highlighting Symptoms, Recovery Challenges, and Treatment Options

FORT LAUDERDALE, FL - November 04, 2026 - PRESSADVANTAGE - Grace Point Treatment Center has published a new educational ...
Courthouse News Service

Judge orders Albertsons to pay Washington $900 million over role in opioid crisis

SEATTLE (CN) — A Washington judge on Thursday ordered Albertsons to pay a whopping $900 million judgment after finding the ...
citybiz

Latigo Biotherapeutics Appoints Todd Smith CEO to Lead Late-Stage Development of Non-Opioid Pain Therapies

Latigo Biotherapeutics, Inc. (Nasdaq: LTGO), a clinical-stage biopharmaceutical company developing non-opioid pain treatments, has appointed Todd N. Smith as President... Read More ...

South Rampart Pharma Selects Validcare to Manage Phase 2 Trial of Non-Opioid SRP-001 for Acute Postoperative Pain

By deploying Validcare’s digital capture platform at CenExel, we eliminate paper transcription delays and standardize ...
RTTNews

Latigo Biotherapeutics (LTGO): Can Nav1.8 Inhibitors Advance Non-Opioid Pain Treatment?

Latigo Biotherapeutics, Inc. (NASDAQ: LTGO), a clinical-stage biopharmaceutical company developing non-opioid medicines for acute and chronic pain, is advancing a pipeline of investigational Nav1.8 ...